Additionally, biliverdin induces angiogenesis and accelerates tumor progression by activating the PI3K/AKT/mTOR signaling pathway, leading to the upregulation of IL-8 and VEGFA in CRC cells55. The gene discussed is CXCL8; the disease is colorectal carcinoma.